Progen Pharmaceuticals terminates agreement to merge with Avexa - MarketLine Financial Deals

Progen Pharmaceuticals terminates agreement to merge with Avexa

Progen Pharmaceuticals terminates agreement to merge with Avexa - MarketLine Financial Deals
Progen Pharmaceuticals terminates agreement to merge with Avexa
Published Mar 09, 2009
3 pages — Published Mar 09, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Progen Pharmaceuticals Limited, a biotechnology company focused on the discovery and development of small molecule-based cancer therapeutics, has terminated its agreement to merge with Avexa Limited, a biotechnology company engaged in the discovery and development of anti-infective pharmaceutical medicines for the treatment of human infectious diseases.

  
Source:
Document ID
MA02386_090316
Country
Ticker
AVX=AU
Ticker
PGL=AU
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Progen Pharmaceuticals terminates agreement to merge with Avexa" Mar 09, 2009. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Progen-Pharmaceuticals-terminates-agreement-to-merge-with-Avexa-2052-2289>
  
APA:
MarketLine Financial Deals. (2009). Progen Pharmaceuticals terminates agreement to merge with Avexa Mar 09, 2009. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Progen-Pharmaceuticals-terminates-agreement-to-merge-with-Avexa-2052-2289>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.